Nalini Saligram, Ph.D.
Nalini Saligram is founder & CEO of Arogya World (www.arogyaworld.org), a global health non-profit committed to changing the course of chronic disease. Through Arogya World, Nalini is putting a spotlight on NCDs, non-communicable diseases, still under-acknowledged by policy makers, and is turning that awareness into on-the-ground action. With a network of thought leaders and partners, she is working on ways to get the world to address NCDs through prevention.
Nalini has led Arogya World to design and implement science-based, large, scalable diabetes prevention programs in India, in schools, workplaces and the community. mDiabetes, a Clinton Global Initiative commitment, which reached 1 million consumers throughout India with text messages on diabetes prevention in 12 languages, has shown promising effectiveness results. Nalini led the implementation of a global survey of 10,000 women in 2014 as part of Arogya World’s advocacy efforts, and is using that to influence governments to take action against NCDs.
Nalini has lived and worked in many parts of the world. She spent more than five years as a global communications executive at Merck, in Philadelphia. Previously, she worked at Glaxo Wellcome in London, Hill & Knowlton in Hong Kong, and Merial in Atlanta.
Nalini has a Ph.D. in biochemistry from the Indian Institute of Science, Bangalore. She serves on the Dean’s Council at the Rollins School of Public Health at Emory University and is a charter member of TiE Midwest. She is currently based in Chicago.
Abstracts this author is presenting: